Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IPACK Block Efficacy as a Part of Multimodal Analgesia in Total Knee Arthroplasty. A Prospective, Randomized, Controlled, Double Blinded Study

NCT03692858 is registered in ClinicalTrials.gov with Asklepieion Voulas General Hospital as lead sponsor.

NCT NCT03692858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03692858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IPACK Block Efficacy as a Part of Multimodal Analgesia in Total Knee Arthroplasty. A Prospective, Randomized, Controlled, Double Blinded Study
Lead sponsor
Asklepieion Voulas General Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
October 1, 2018
Completion date
July 31, 2020
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

total knee arthroplasty